Clinical Trial Update: LUMINOS-103: A Basket Trial of Safety & Efficacy of Lerapolturev With or Without Checkpoint Inhibitors [Phase 1, Phase 2]

View source ↗

Summary

Terminated basket trial evaluating Lerapolturev with or without checkpoint inhibitors in solid tumors, including bladder cancer and non-muscle-invasive bladder …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Bladder Cancer
• Non-muscle Invasive Bladder Cancer

Drugs mentioned

• Lerapolturev (lerapolturev)

Snippet

Sponsor: Istari Oncology, Inc. | Conditions: Solid Tumor, Bladder Cancer | Phase 1, Phase 2 | Status: TERMINATED | Results posted: 2024-10-24